Best Low Price Stocks To Invest In 2014

Best Low Price Stock s To Invest In 2014: Arrowhead Research Corporation(ARWR)

Arrowhead Research Corporation, a clinical stage nanomedicine company, through its subsidiaries, develops therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. It focuses on the design and development of therapeutic agents for the treatment of cancer and obesity, as well as healing wounded or diseased tissue based on nucleic acid delivery, siRNA chemistry, and tissue targeting intellectual properties. The company?s lead products include CALAA-01, an oncology drug candidate based on the gene silencing RNA interference (RNAi) mechanism; and Adipotide, an anti-obesity peptide that targets and kills the blood vessels that feed white adipose tissue. It also plans to develop its internal preclinical and clinical pipeline, including RONDEL-enabled siRNA drug candidates, Dynamic Polyconjugate (DPC)-enabled drug candidate development, and the non-siRNA-based anti-obesity drug candidate, Adipotide. The company, formerly known as InterActive Group, Inc., was founded in 2003 and is headquartered in Pasadena, California.

Advisors' Opinion:

• [By John Udovich]

  So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year – making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

• [By Roberto Pedone]

  Another under-$10 nanotechnology player that's quickly moving within range of triggering a big breakout trade is Arr! owhead Research (ARWR), which forms, acquires and operates subsidiaries commercializing innovative nanotechnologies. This stock has been on fire so far in 2013, with shares up a whopping 284%.

  If you take a look at the chart for Arrowhead Research, you'll notice that this stock has been uptrending strong for the last five months, with shares soaring higher from its low of $1.81 to its recent high of $8.88 a share. During that uptrend, shares of ARWR have been consistently making higher lows and higher highs, which is bullish technical price action. Shares of ARWR took out some near-term overhead resistance levels on Friday at $7.84 to $7.99 a share. That move is now quickly pushing shares of ARWR within range of triggering another big breakout trade.

  Market players should now look for long-biased trades in ARWR if it manages to break out above Friday's high of $8.37 a share to its 52-week high at $8.88 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 500,600 shares. If that breakout hits soon, then ARWR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $11 to $12 a share.

  Traders can look to buy ARWR off weakness to anticipate that breakout and simply use a stop that sits right around its 50-day moving average of $7.10 a share. One can also buy ARWR off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

source from Top Stocks Blog:http://www.topstocksblog.com/best-low-price-stocks-to-invest-in-2014.html